REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Novo Nordisk Pharmaceutical Services" Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Marketing Consulting Services | Research and Development in Biotechnology (except Nanobiotechnology) | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services | Convention and Trade Show Organizers | Educational Services | All Other Miscellaneous Schools and Instruction | All Other Amusement and Recreation Industries
Full name: "Novo Nordisk Pharmaceutical Services" Sp. z o.o. Profile Updated: December 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Novo Nordisk Pharmaceutical Services Sp. z o.o. is a Polish subsidiary of the global healthcare company Novo Nordisk. The company specializes in scientific research and development services. Established on September 12, 2002, it operates from its main office in Warsaw, Poland. Novo Nordisk Pharmaceutical Services focuses on developing innovative therapies for serious chronic diseases, including diabetes.

Headquarters
Ul. Krakowiakow 46
Warsaw; Mazowieckie; Postal Code: 02-255

Contact Details: Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.

Website: http://www.novonordisk.com

Basic Information
Total Employees:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Incorporation Date:
September 12, 2002
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
W Organie Czlonek Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.84%▲
Total operating revenue
19.12%▲
Operating profit (EBIT)
7.22%▲
EBITDA
7.22%▲
Net Profit (Loss) for the Period
12.29%▲
Total assets
39.68%▲
Total equity
31.1%▲
Operating Profit Margin (ROS)
-0.2%▼
Net Profit Margin
-0.09%▼
Return on Equity (ROE)
-3.97%▼
Quick Ratio
-0.06%▼

Similar companies

Eurocash S.A.
 
Neuca S.A.
Pepco Poland Sp. z o.o.
 
Viterra Polska Sp. z o.o.
Samsung Electronics Polska Sp. z o.o.
 
Polska Grupa Farmaceutyczna S.A.
A.P.N. Promise S.A.
 
"Osadkowski - Cebulski" Sp. z o.o.
Msd Polska Dystrybucja Sp. z o.o.
 
Medi&More Sp. z o.o.
"Colgate-Palmolive (Poland)" Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo